Literature DB >> 7876904

On the use of LUDI to search the Fine Chemicals Directory for ligands of proteins of known three-dimensional structure.

H J Böhm1.   

Abstract

It is shown that the computer program LUDI can be used to search large database of three-dimensional structures for putative ligands of proteins with known 3D structure. As an example, a subset of approximately 30,000 small molecules (with less than 40 atoms and 0-2 rotatable bonds) from the Fine Chemicals Directory has been used in the search for possible novel ligands for four different proteins (trypsin, streptavidin, purine nucleoside phosphorylase and HIV protease). For trypsin and streptavidin, known ligands or substructures of known ligands are retrieved as top-scoring hits. In addition, a number of new interesting structures are found in all considered cases. Therefore, the method holds promise to retrieve automatically protein ligands from a 3D database if the 3D structure of the target protein is known.

Mesh:

Substances:

Year:  1994        PMID: 7876904     DOI: 10.1007/bf00123669

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  24 in total

1.  STUDIES ON THE ACTIVE CENTER OF TRYPSIN. THE BINDING OF AMIDINES AND GUANIDINES AS MODELS OF THE SUBSTRATE SIDE CHAIN.

Authors:  M MARES-GUIA; E SHAW
Journal:  J Biol Chem       Date:  1965-04       Impact factor: 5.157

2.  CLIX: a search algorithm for finding novel ligands capable of binding proteins of known three-dimensional structure.

Authors:  M C Lawrence; P C Davis
Journal:  Proteins       Date:  1992-01

Review 3.  Structure-based strategies for drug design and discovery.

Authors:  I D Kuntz
Journal:  Science       Date:  1992-08-21       Impact factor: 47.728

4.  Three-dimensional structure of human erythrocytic purine nucleoside phosphorylase at 3.2 A resolution.

Authors:  S E Ealick; S A Rule; D C Carter; T J Greenhough; Y S Babu; W J Cook; J Habash; J R Helliwell; J D Stoeckler; R E Parks
Journal:  J Biol Chem       Date:  1990-01-25       Impact factor: 5.157

5.  The computer program LUDI: a new method for the de novo design of enzyme inhibitors.

Authors:  H J Böhm
Journal:  J Comput Aided Mol Des       Date:  1992-02       Impact factor: 3.686

Review 6.  3D database searching in drug design.

Authors:  Y C Martin
Journal:  J Med Chem       Date:  1992-06-12       Impact factor: 7.446

Review 7.  On the rational design of renin inhibitors: X-ray studies of aspartic proteinases complexed with transition-state analogues.

Authors:  T L Blundell; J Cooper; S I Foundling; D M Jones; B Atrash; M Szelke
Journal:  Biochemistry       Date:  1987-09-08       Impact factor: 3.162

8.  The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure.

Authors:  H J Böhm
Journal:  J Comput Aided Mol Des       Date:  1994-06       Impact factor: 3.686

9.  Design, activity, and 2.8 A crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease.

Authors:  J Erickson; D J Neidhart; J VanDrie; D J Kempf; X C Wang; D W Norbeck; J J Plattner; J W Rittenhouse; M Turon; N Wideburg
Journal:  Science       Date:  1990-08-03       Impact factor: 47.728

10.  New hydrogen-bond potentials for use in determining energetically favorable binding sites on molecules of known structure.

Authors:  D N Boobbyer; P J Goodford; P M McWhinnie; R C Wade
Journal:  J Med Chem       Date:  1989-05       Impact factor: 7.446

View more
  30 in total

1.  Computer based screening of compound databases: 1. Preselection of benzamidine-based thrombin inhibitors.

Authors:  T Fox; E E Haaksma
Journal:  J Comput Aided Mol Des       Date:  2000-07       Impact factor: 3.686

2.  Computer-aided design and activity prediction of leucine aminopeptidase inhibitors.

Authors:  J Grembecka; W A Sokalski; P Kafarski
Journal:  J Comput Aided Mol Des       Date:  2000-08       Impact factor: 3.686

3.  Evaluation of designed ligands by a multiple screening method: application to glycogen phosphorylase inhibitors constructed with a variety of approaches.

Authors:  S S So; M Karplus
Journal:  J Comput Aided Mol Des       Date:  2001-07       Impact factor: 3.686

4.  A Bayesian molecular interaction library.

Authors:  Ville-Veikko Rantanen; Mats Gyllenberg; Timo Koski; Mark S Johnson
Journal:  J Comput Aided Mol Des       Date:  2003-07       Impact factor: 3.686

5.  Structure-Based Screen Identification of a Mammalian Ste20-like Kinase 4 (MST4) Inhibitor with Therapeutic Potential for Pituitary Tumors.

Authors:  Weipeng Xiong; Christopher J Matheson; Mei Xu; Donald S Backos; Taylor S Mills; Smita Salian-Mehta; Katja Kiseljak-Vassiliades; Philip Reigan; Margaret E Wierman
Journal:  Mol Cancer Ther       Date:  2015-12-31       Impact factor: 6.261

6.  Challenges of fragment screening.

Authors:  Diane Joseph-McCarthy
Journal:  J Comput Aided Mol Des       Date:  2009-06-30       Impact factor: 3.686

7.  A computational study on cannabinoid receptors and potent bioactive cannabinoid ligands: homology modeling, docking, de novo drug design and molecular dynamics analysis.

Authors:  Serdar Durdagi; Manthos G Papadopoulos; Panagiotis G Zoumpoulakis; Catherine Koukoulitsa; Thomas Mavromoustakos
Journal:  Mol Divers       Date:  2009-06-18       Impact factor: 2.943

Review 8.  Prediction of binding constants of protein ligands: a fast method for the prioritization of hits obtained from de novo design or 3D database search programs.

Authors:  H J Böhm
Journal:  J Comput Aided Mol Des       Date:  1998-07       Impact factor: 3.686

9.  Towards the automatic design of synthetically accessible protein ligands: peptides, amides and peptidomimetics.

Authors:  H J Böhm
Journal:  J Comput Aided Mol Des       Date:  1996-08       Impact factor: 3.686

10.  Dimeric isoxazolyl-1,4-dihydropyridines have enhanced binding at the multi-drug resistance transporter.

Authors:  Scott A Steiger; Chun Li; Donald S Backos; Philip Reigan; N R Natale
Journal:  Bioorg Med Chem       Date:  2017-04-08       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.